601 related articles for article (PubMed ID: 9016562)
1. Effects of variations in length of hammerhead ribozyme antisense arms upon the cleavage of longer RNA substrates.
Sioud M
Nucleic Acids Res; 1997 Jan; 25(2):333-8. PubMed ID: 9016562
[TBL] [Abstract][Full Text] [Related]
2. Hammerhead ribozymes targeted to the FBN1 mRNA can discriminate a single base mismatch between ribozyme and target.
Phylactou LA; Tsipouras P; Kilpatrick MW
Biochem Biophys Res Commun; 1998 Aug; 249(3):804-10. PubMed ID: 9731217
[TBL] [Abstract][Full Text] [Related]
3. A three-nucleotide helix I is sufficient for full activity of a hammerhead ribozyme: advantages of an asymmetric design.
Tabler M; Homann M; Tzortzakaki S; Sczakiel G
Nucleic Acids Res; 1994 Sep; 22(19):3958-65. PubMed ID: 7937118
[TBL] [Abstract][Full Text] [Related]
4. Extension of helix II of an HIV-1-directed hammerhead ribozyme with long antisense flanks does not alter kinetic parameters in vitro but causes loss of the inhibitory potential in living cells.
Homann M; Tabler M; Tzortzakaki S; Sczakiel G
Nucleic Acids Res; 1994 Sep; 22(19):3951-7. PubMed ID: 7524030
[TBL] [Abstract][Full Text] [Related]
5. Cleavage of full-length beta APP mRNA by hammerhead ribozymes.
Denman RB
Nucleic Acids Res; 1993 Aug; 21(17):4119-25. PubMed ID: 8371986
[TBL] [Abstract][Full Text] [Related]
6. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes.
Kronenwett R; Haas R; Sczakiel G
J Mol Biol; 1996 Jun; 259(4):632-44. PubMed ID: 8683570
[TBL] [Abstract][Full Text] [Related]
7. The influence of imperfectly paired helices I and III on the catalytic activity of hammerhead ribozymes.
Zoumadakis M; Neubert WJ; Tabler M
Nucleic Acids Res; 1994 Dec; 22(24):5271-8. PubMed ID: 7816616
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 TAR as anchoring site for optimized catalytic RNAs.
Puerta-Fernandez E; Barroso-del Jesus A; Romero-López C; Berzal-Herranz A
Biol Chem; 2003 Mar; 384(3):343-50. PubMed ID: 12715885
[TBL] [Abstract][Full Text] [Related]
9. Design and expression of chimeric U1/ribozyme transgenes.
Abounader R; Montgomery R; Dietz H; Laterra J
Methods Mol Biol; 2004; 252():209-19. PubMed ID: 15017051
[TBL] [Abstract][Full Text] [Related]
10. Minimal Hammerhead Ribozymes with Uncompromised Catalytic Activity.
O'Rourke SM; Estell W; Scott WG
J Mol Biol; 2015 Jul; 427(14):2340-7. PubMed ID: 25981451
[TBL] [Abstract][Full Text] [Related]
11. The antisense sequence of the HIV-1 TAR stem-loop structure covalently linked to the hairpin ribozyme enhances its catalytic activity against two artificial substrates.
Pérez-Ruiz M; Sievers D; García-López PA; Berzal-Herranz A
Antisense Nucleic Acid Drug Dev; 1999 Feb; 9(1):33-42. PubMed ID: 10192287
[TBL] [Abstract][Full Text] [Related]
12. Examination of the catalytic fitness of the hammerhead ribozyme by in vitro selection.
Tang J; Breaker RR
RNA; 1997 Aug; 3(8):914-25. PubMed ID: 9257650
[TBL] [Abstract][Full Text] [Related]
13. Cleavage of collagen RNA transcripts by hammerhead ribozymes in vitro is mutation-specific and shows competitive binding effects.
Grassi G; Forlino A; Marini JC
Nucleic Acids Res; 1997 Sep; 25(17):3451-8. PubMed ID: 9254703
[TBL] [Abstract][Full Text] [Related]
14. The effect of structure in a long target RNA on ribozyme cleavage efficiency.
Campbell TB; McDonald CK; Hagen M
Nucleic Acids Res; 1997 Dec; 25(24):4985-93. PubMed ID: 9396806
[TBL] [Abstract][Full Text] [Related]
15. A helix 1-extended hairpin ribozyme exhibits altered cleavage behavior in vitro.
Moosbauer J; Tabler M
Antisense Nucleic Acid Drug Dev; 1997 Apr; 7(2):79-87. PubMed ID: 9149843
[TBL] [Abstract][Full Text] [Related]
16. Structural similarities between hammerhead ribozymes and the spliceosomal RNAs could be responsible for lack of ribozyme cleavage in yeast.
Castanotto D; Li H; Chow W; Rossi JJ; Deshler JO
Antisense Nucleic Acid Drug Dev; 1998 Feb; 8(1):1-13. PubMed ID: 9512091
[TBL] [Abstract][Full Text] [Related]
17. Length variation of helix III in a hammerhead ribozyme and its influence on cleavage activity.
Hammann C; Martinez E; Moosbauer J; Hormes R; Tabler M
Antisense Nucleic Acid Drug Dev; 1999 Feb; 9(1):25-31. PubMed ID: 10192286
[TBL] [Abstract][Full Text] [Related]
18. Efficient improvement of hammerhead ribozyme mediated cleavage of long substrates by oligonucleotide facilitators.
Jankowsky E; Schwenzer B
Biochemistry; 1996 Dec; 35(48):15313-21. PubMed ID: 8952482
[TBL] [Abstract][Full Text] [Related]
19. The subcellular localization and length of hammerhead ribozymes determine efficacy in human cells.
Hormes R; Homann M; Oelze I; Marschall P; Tabler M; Eckstein F; Sczakiel G
Nucleic Acids Res; 1997 Feb; 25(4):769-75. PubMed ID: 9016627
[TBL] [Abstract][Full Text] [Related]
20. cis-Acting 5' hammerhead ribozyme optimization for in vitro transcription of highly structured RNAs.
Meyer M; Masquida B
Methods Mol Biol; 2014; 1086():21-40. PubMed ID: 24136596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
